ID19813A - Benzotiofen, formulasi yang mengandungnya, dan metodenya - Google Patents

Benzotiofen, formulasi yang mengandungnya, dan metodenya

Info

Publication number: ID19813A
Authority: ID; Indonesia
Prior art keywords: benzotiofen; formulation; methods
Prior art date: 1996-03-26

Application number

IDP970956A

Other languages

English (en)

Inventor

Gordon Nelson Arbuthnot

Brian Weston Dalder

Kerry John Hartauer

Wayne Douglas Luke

Robert Eugene Stratford Jr

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-26

Filing date

1997-03-24

Publication date

1998-08-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID19813(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-04-04 Priority claimed from GBGB9607110.5A external-priority patent/GB9607110D0/en

1997-03-24 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1998-08-06 Publication of ID19813A publication Critical patent/ID19813A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Thin Film Transistor (AREA)

IDP970956A 1996-03-26 1997-03-24 Benzotiofen, formulasi yang mengandungnya, dan metodenya ID19813A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1416796P	1996-03-26	1996-03-26
GBGB9607110.5A GB9607110D0 (en)	1996-04-04	1996-04-04	Benzothiopenes formulations containing same and methods

Publications (1)

Publication Number	Publication Date
ID19813A true ID19813A (id)	1998-08-06

Family

ID=26309061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP970956A ID19813A (id)	1996-03-26	1997-03-24	Benzotiofen, formulasi yang mengandungnya, dan metodenya

Country Status (30)

Country	Link
EP (2)	EP2266560A1 (id)
JP (5)	JP2000507268A (id)
CN (1)	CN1162153C (id)
AR (1)	AR006387A1 (id)
AT (1)	ATE464897T1 (id)
AU (1)	AU723797B2 (id)
BR (1)	BR9708248A (id)
CA (1)	CA2250191C (id)
CO (1)	CO4780022A1 (id)
CZ (1)	CZ300341B6 (id)
DE (1)	DE69739855D1 (id)
DK (1)	DK0910369T3 (id)
EA (1)	EA001257B1 (id)
ES (1)	ES2341399T3 (id)
HK (1)	HK1020671A1 (id)
ID (1)	ID19813A (id)
IL (2)	IL140742A (id)
ME (2)	ME00074B (id)
MY (1)	MY115533A (id)
NO (1)	NO320894B1 (id)
NZ (1)	NZ332036A (id)
PL (1)	PL191148B1 (id)
PT (1)	PT910369E (id)
RO (1)	RO121117B1 (id)
SI (1)	SI0910369T1 (id)
TR (1)	TR199801915T2 (id)
TW (1)	TW513421B (id)
UA (1)	UA57596C2 (id)
WO (1)	WO1997035571A1 (id)
YU (1)	YU41898A (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME00074B (me) *	1996-03-26	2010-10-10	Lilly Co Eli	Benzotiofeni, formulacije koje ih sadrže i proizvod
YU42397A (sh) *	1996-10-30	2000-10-30	Eli Lilly And Company	Korišćenje raloksifena za pripremu leka
ZA979723B (en)	1996-10-30	1999-07-29	Lilly Co Eli	Methods of preventing breast cancer.
EP1826205A1 (en) *	2002-09-30	2007-08-29	A/S GEA Farmaceutisk Fabrik	Novel raloxifene succinic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
KR20090082399A (ko)	2006-10-17	2009-07-30	씨아이피엘에이 엘티디.	벤조티오펜 화합물의 결정형 및 그의 제조방법
CL2008003799A1 (es) *	2007-12-21	2009-12-18	Synthon Bv	Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
EP3202420B1 (en) *	2008-12-11	2020-03-04	Besins Healthcare Luxembourg SARL	Transdermal pharmaceutical compositions comprising a serm
WO2011000581A2 (en)	2009-07-02	2011-01-06	Synthon B.V.	Raloxifene composition
WO2011099942A1 (en)	2010-02-09	2011-08-18	Silverstone Pharma	New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
GB201515387D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
GB201515391D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
US9872838B2 (en)	2016-05-30	2018-01-23	Sun Pharmaceutical Industries Limited	Raloxifene sprinkle composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4133814A (en) *	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) *	1981-04-03	1983-04-19	Eli Lilly And Company	Synthesis of acylated benzothiophenes
US4418068A (en)	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
JPS63112519A (ja) *	1986-10-28	1988-05-17	Shin Etsu Chem Co Ltd	ニフエジピン製剤の製造方法
NL9000634A (nl) *	1990-03-20	1991-10-16	Catharina Ziekenhuis Stichting	Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
KR100294525B1 (ko) *	1992-10-09	2001-09-17	후루타 다케시	미세한조립체의제조방법
US5482949A (en) *	1993-03-19	1996-01-09	Eli Lilly And Company	Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5482950A (en) *	1993-10-15	1996-01-09	Eli Lilly And Company	Methods for lowering serum cholesterol
EP0736007A4 (en) *	1993-12-21	1997-03-19	Lilly Co Eli	NON-PEPTIDE ANTAGONISTS OF TACHYKININ RECEPTORS
US5478847A (en) *	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol
CA2143263C (en) *	1994-03-02	2002-01-08	Kerry John Hartauer	Orally administrable raloxifene formulations
US6723739B1 (en)	1994-05-20	2004-04-20	Eli Lilly And Company	Glucopyranoside benzothiophenes
US5494920A (en) *	1994-08-22	1996-02-27	Eli Lilly And Company	Methods of inhibiting viral replication
CO4410190A1 (es)	1994-09-19	1997-01-09	Lilly Co Eli	3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5494929A (en)	1995-01-12	1996-02-27	Eli Lilly And Company	Methods of inhibiting growth hormone effects
US5532254A (en) *	1995-06-07	1996-07-02	Eli Lilly And Company	Modulation of calcium channels using benzothiophenes
ME00074B (me) *	1996-03-26	2010-10-10	Lilly Co Eli	Benzotiofeni, formulacije koje ih sadrže i proizvod

1997
- 1997-03-20 ME MEP-2008-183A patent/ME00074B/me unknown
- 1997-03-20 IL IL140742A patent/IL140742A/en not_active IP Right Cessation
- 1997-03-20 CN CNB971932492A patent/CN1162153C/zh not_active Expired - Lifetime
- 1997-03-20 NZ NZ332036A patent/NZ332036A/en not_active IP Right Cessation
- 1997-03-20 WO PCT/US1997/004259 patent/WO1997035571A1/en not_active Application Discontinuation
- 1997-03-20 CZ CZ0305398A patent/CZ300341B6/cs not_active IP Right Cessation
- 1997-03-20 PT PT97915139T patent/PT910369E/pt unknown
- 1997-03-20 EP EP09165873A patent/EP2266560A1/en not_active Withdrawn
- 1997-03-20 EA EA199800865A patent/EA001257B1/ru not_active IP Right Cessation
- 1997-03-20 ME MEP-183/08A patent/MEP18308A/xx unknown
- 1997-03-20 DK DK97915139.6T patent/DK0910369T3/da active
- 1997-03-20 IL IL12632097A patent/IL126320A/en not_active IP Right Cessation
- 1997-03-20 AU AU22154/97A patent/AU723797B2/en not_active Expired
- 1997-03-20 ES ES97915139T patent/ES2341399T3/es not_active Expired - Lifetime
- 1997-03-20 CA CA002250191A patent/CA2250191C/en not_active Expired - Fee Related
- 1997-03-20 PL PL329051A patent/PL191148B1/pl unknown
- 1997-03-20 RO RO98-01419A patent/RO121117B1/ro unknown
- 1997-03-20 JP JP9534467A patent/JP2000507268A/ja not_active Withdrawn
- 1997-03-20 TR TR1998/01915T patent/TR199801915T2/xx unknown
- 1997-03-20 AT AT97915139T patent/ATE464897T1/de active
- 1997-03-20 EP EP97915139A patent/EP0910369B1/en not_active Revoked
- 1997-03-20 UA UA98095028A patent/UA57596C2/uk unknown
- 1997-03-20 DE DE69739855T patent/DE69739855D1/de not_active Expired - Lifetime
- 1997-03-20 BR BR9708248A patent/BR9708248A/pt active IP Right Grant
- 1997-03-20 SI SI9730794T patent/SI0910369T1/sl unknown
- 1997-03-21 CO CO97015459A patent/CO4780022A1/es unknown
- 1997-03-24 MY MYPI97001237A patent/MY115533A/en unknown
- 1997-03-24 ID IDP970956A patent/ID19813A/id unknown
- 1997-03-25 AR ARP970101196A patent/AR006387A1/es not_active Application Discontinuation
- 1997-03-26 TW TW086103861A patent/TW513421B/zh not_active IP Right Cessation
1998
- 1998-09-24 NO NO19984444A patent/NO320894B1/no not_active IP Right Cessation
- 1998-09-25 YU YU41898A patent/YU41898A/sh unknown
1999
- 1999-10-27 HK HK99104833.5A patent/HK1020671A1/xx not_active IP Right Cessation
2008
- 2008-09-04 JP JP2008227311A patent/JP2009019057A/ja not_active Withdrawn
2013
- 2013-06-04 JP JP2013118034A patent/JP2013166797A/ja not_active Withdrawn
2015
- 2015-06-09 JP JP2015116526A patent/JP6095725B2/ja not_active Expired - Lifetime
2016
- 2016-03-23 JP JP2016059108A patent/JP6095821B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP6095821B2 (ja)	2017-03-15
AR006387A1 (es)	1999-08-25
CA2250191A1 (en)	1997-10-02
YU41898A (sh)	1999-07-28
NO320894B1 (no)	2006-02-06
RO121117B1 (ro)	2006-12-29
ATE464897T1 (de)	2010-05-15
AU2215497A (en)	1997-10-17
UA57596C2 (uk)	2003-06-16
ME00074B (me)	2010-10-10
JP2009019057A (ja)	2009-01-29
SI0910369T1 (sl)	2010-08-31
NO984444L (no)	1998-11-26
PL329051A1 (en)	1999-03-01
MEP18308A (en)	2010-06-10
IL140742A (en)	2012-02-29
ES2341399T3 (es)	2010-06-18
JP2013166797A (ja)	2013-08-29
NZ332036A (en)	1999-04-29
PT910369E (pt)	2010-06-04
CZ305398A3 (cs)	1999-05-12
BR9708248A (pt)	1999-07-27
TR199801915T2 (xx)	1998-12-21
WO1997035571A1 (en)	1997-10-02
NO984444D0 (no)	1998-09-24
EP0910369A4 (en)	2001-03-21
DE69739855D1 (de)	2010-06-02
IL126320A0 (en)	1999-05-09
IL140742A0 (en)	2002-02-10
CA2250191C (en)	2005-11-15
JP6095725B2 (ja)	2017-03-15
EP0910369A1 (en)	1999-04-28
IL126320A (en)	2001-08-08
JP2000507268A (ja)	2000-06-13
CN1213967A (zh)	1999-04-14
CO4780022A1 (es)	1999-05-26
TW513421B (en)	2002-12-11
PL191148B1 (pl)	2006-03-31
CZ300341B6 (cs)	2009-04-22
AU723797B2 (en)	2000-09-07
DK0910369T3 (da)	2010-07-26
EP0910369B1 (en)	2010-04-21
JP2016106159A (ja)	2016-06-16
HK1020671A1 (en)	2000-05-19
EP2266560A1 (en)	2010-12-29
CN1162153C (zh)	2004-08-18
JP2015157865A (ja)	2015-09-03
MY115533A (en)	2003-07-31
EA001257B1 (ru)	2000-12-25
EA199800865A1 (ru)	1999-02-25

Publication	Publication Date	Title
ID28846A (id)	2001-07-05	2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID25528A (id)	2000-10-12	Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID19422A (id)	1998-07-09	Piridina dan bifenil tersubstitusi
NO971041D0 (no)	1997-03-06	Brönn-frakoplingsverktöy
TR199501560A2 (tr)	1996-07-21	Kademeli olarak saliverilen kafein formülasyonu.
ID18046A (id)	1998-02-19	Senyawa siklik campuran, pembuatan dan penngunaannya.
ID19824A (id)	1998-08-06	Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
FI971620A0 (fi)	1997-04-16	Autentikointimenetelmä
ID23575A (id)	2000-05-04	Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID23439A (id)	2000-04-20	Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID25543A (id)	2000-10-12	Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID16202A (id)	1997-09-11	Sistem pemesanan yang memberikan penjelajahan sleksifer dan metodanya
DE69709613D1 (de)	2002-02-21	Schminkdose
FI960450A0 (fi)	1996-01-31	Lukitusteline
ID16889A (id)	1997-11-20	Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID29052A (id)	2001-07-26	Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
ID18456A (id)	1998-04-09	Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21770A (id)	1999-07-22	Plester yang mengandung felbinak
ID19813A (id)	1998-08-06	Benzotiofen, formulasi yang mengandungnya, dan metodenya
ID23258A (id)	2000-04-05	Penarik pemberian-menyilang dan metodenya
ID16587A (id)	1997-10-16	Koproduksi 6-aminokapronitril dan heksametilendiamin
ID18459A (id)	1998-04-09	Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID24633A (id)	2000-07-27	Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
DE69712037D1 (de)	2002-05-23	Mischkopfdüse
NL1007839A1 (nl)	1998-06-23	Formulering en gebruik.